Doctors consulting

Helping to Reshape NASH Clinical Trials

ELF Test indicated as top-performing biomarker in NIMBLE study

Siemens Healthineers is proud to be recognized in Stage I of the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE) study.

The results of the study were recently presented at The Liver Meeting 2021 and showed that the Enhanced Liver Fibrosis (ELF™) Test performed the best of the five blood biomarkers selected for the study.

View Abstract: Primary Results of the NIMBLE Stage 1-NASH CRN Study of Circulating Biomarkers for Nonalcoholic Steatohepatitis and its Activity and Fibrosis Stage

Find out More